TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 67 filers reported holding TRICIDA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,000 | -97.7% | 3,767 | -8.9% | 0.00% | – |
Q3 2022 | $43,000 | +514.3% | 4,135 | +501.9% | 0.00% | – |
Q2 2022 | $7,000 | -87.3% | 687 | -89.8% | 0.00% | – |
Q1 2022 | $55,000 | +103.7% | 6,747 | +8.8% | 0.00% | – |
Q2 2021 | $27,000 | -73.0% | 6,202 | -67.0% | 0.00% | – |
Q1 2021 | $100,000 | -21.3% | 18,809 | +4.2% | 0.00% | – |
Q4 2020 | $127,000 | -27.0% | 18,043 | -6.1% | 0.00% | – |
Q3 2020 | $174,000 | -53.4% | 19,225 | +41.8% | 0.00% | – |
Q2 2020 | $373,000 | +24.3% | 13,557 | -0.6% | 0.00% | – |
Q1 2020 | $300,000 | -47.5% | 13,632 | -10.0% | 0.00% | – |
Q4 2019 | $571,000 | +31.0% | 15,149 | +7.2% | 0.00% | – |
Q3 2019 | $436,000 | +101.9% | 14,125 | +158.0% | 0.00% | – |
Q2 2019 | $216,000 | +369.6% | 5,475 | +356.2% | 0.00% | – |
Q1 2019 | $46,000 | +283.3% | 1,200 | +140.0% | 0.00% | – |
Q4 2018 | $12,000 | -53.8% | 500 | -40.9% | 0.00% | – |
Q3 2018 | $26,000 | +766.7% | 846 | +746.0% | 0.00% | – |
Q2 2018 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 7,132,079 | $69,039,000 | 13.60% |
STONEHILL CAPITAL MANAGEMENT LLC | 1,436,736 | $13,908,000 | 9.25% |
COMMODORE CAPITAL LP | 2,028,453 | $19,635,000 | 4.15% |
Tri Locum Partners LP | 731,142 | $7,077,000 | 2.90% |
GREAT POINT PARTNERS LLC | 1,164,763 | $11,275,000 | 2.70% |
Frazier Life Sciences Management, L.P. | 2,082,093 | $20,155,000 | 1.90% |
Orbimed Advisors | 10,280,947 | $99,520,000 | 1.80% |
Deep Track Capital, LP | 2,732,117 | $26,447,000 | 1.74% |
Lion Point Capital, LP | 1,826,729 | $12,034,000 | 1.37% |
Bleichroeder LP | 450,000 | $4,356,000 | 0.90% |